Close Menu

NEW YORK (GenomeWeb) – AbbVie today announced it is renewing its association with the Structural Genomics Consortium (SGC) for five years with a C$7.5 million (US$5.6 million) cash sponsorship.

The money will be used for open access research to discover new medicines, the firm said in a statement, focusing on chemical tools to explore classes of proteins such as those involved in ion channels, solute carrier channels, and epigenetic regulation.

AbbVie has supported the consortium since 2012.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Washington Post reports on researchers' efforts to determine the effect of an increasingly common SARS-CoV-2 mutation.

Florida Politics reports Florida's law barring life, long-term care, and disability insurers from using genetic information in coverage decisions went into effect at the beginning of July.

A new analysis finds a link between popular media coverage of a scientific study and how often that paper is cited.

In Nature this week: CRISPR approaches to editing plant genomes, way to speed up DNA-PAINT, and more.